ENTITY

Symbio Pharmaceuticals (4582 JP)

43
Analysis
Health Care • Japan
Symbio Pharmaceuticals Limited develops and commercializes prescription drugs n oncology, hematology and auto-immune disease for Japan and other Asia Pacific markets.
more
•16 Jun 2020 06:33

🇯🇵 JAPAN - Stress Tests Part 2 - Operating Cash Flow & Accruals

STRESS TESTS - This Insight is the second in our Japan Stress Test series in which we endeavour to assess where business risk is concentrated...

Logo
531 Views
Share
•28 Dec 2018 17:53

Japan Pharma - Top Picks (28 Dec 2018)

                                                                                                                                                   ...

•18 Dec 2018 14:43

Japan Pharma - Top Picks

While Gni Group Ltd (2160 JP) is our high risk-high return pick, Mitsubishi Tanabe Pharma (4508 JP)  is a contrarian call in anticipation of value...

•09 Oct 2018 11:49

Smartkarma’s Week that Was in JP/​KR: King Street Vs. Toshiba, Korea's Donki, and SKT Split

Below is the list of the Japan/Korea related posts put on the Smartkarma platform last week. It was a holiday week for both Japan and Korea. So, we...

Logo
510 Views
Share
•21 Jun 2021 17:43

Asia Shorts: Geely, Ganfeng, Pharmaron, Evergrande, Fujitsu, Canon, Renesas, Toshiba, LGD, Doosan

The Insight looks at large short interest movements across HK, Japan, Korea and Taiwan stocks and highlights large increases/decreases in shorts to...

Logo
345 Views
Share
x